牛叉诊股

[{"date":"2025.04.18","stock":"0.72","trade":"-0.37","ind":"0.23"},{"date":"2025.04.17","stock":"0.36","trade":"0.74","ind":"-0.16"},{"date":"2025.04.16","stock":"-1.42","trade":"-1.23","ind":"-0.85"},{"date":"2025.04.15","stock":"-0.70","trade":"0.11","ind":"-0.27"},{"date":"2025.04.14","stock":"1.79","trade":"1.30","ind":"0.51"},{"date":"2025.04.11","stock":"0.00","trade":"-0.33","ind":"0.82"},{"date":"2025.04.10","stock":"1.09","trade":"1.99","ind":"2.25"},{"date":"2025.04.09","stock":"0.00","trade":"1.27","ind":"1.22"},{"date":"2025.04.08","stock":"-2.82","trade":"1.75","ind":"0.64"},{"date":"2025.04.07","stock":"-10.13","trade":"-10.73","ind":"-9.66"},{"date":"2025.04.03","stock":"1.61","trade":"0.20","ind":"-1.40"},{"date":"2025.04.02","stock":"4.01","trade":"0.05","ind":"0.09"},{"date":"2025.04.01","stock":"3.46","trade":"2.74","ind":"-0.01"},{"date":"2025.03.31","stock":"-2.36","trade":"-1.80","ind":"-0.97"},{"date":"2025.03.28","stock":"-1.33","trade":"-1.13","ind":"-0.57"},{"date":"2025.03.27","stock":"0.33","trade":"0.27","ind":"0.23"},{"date":"2025.03.26","stock":"0.67","trade":"0.06","ind":"-0.05"},{"date":"2025.03.25","stock":"1.02","trade":"1.13","ind":"-0.43"},{"date":"2025.03.24","stock":"-3.61","trade":"-1.69","ind":"0.07"},{"date":"2025.03.21","stock":"0.33","trade":"-1.72","ind":"-1.76"},{"date":"2025.03.20","stock":"0.33","trade":"-0.71","ind":"-0.91"}]

瑞康医药,深证成指,医药商业指数

压力支撑

该股压力位为2.80元，支撑位为2.76元。

[{"text":"\u538b\u529b\u4f4d","value":"2.80","date":1744905600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"2.76","date":1744905600,"color":"0x0b52a1"}]

多空趋势

空头行情中，目前反弹趋势有所减缓，投资者可适当关注。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：3.0资金面打败了35%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

医药商业行业，近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。

更新时间：04月18日 20:32

机构今日流向(万元)	-761.09	机构5日流向(万元)	-2216.20
机构10日流向(万元)	-3710.52	机构20日流向(万元)	-8385.37

机构持仓

2024-12-31 与 2024-06-30 相比，主力机构持仓量减少15288.57万股，其中基金净增仓5家，主力净减仓12家，暂未发现中长期投资价值。

截止2024-12-31，共18家主力机构（基金18家），持仓量总计161.81万股，占流通A股0.12%
其中，基金持仓与2024-06-30相比：
增仓：7家，增持 74.32万股
减仓：2家，减持 0.34万股
新出现在主力名单中：9家，持有8.6万股
从主力名单中消失：21家，原持有15371.15万股

消息面诊股

诊断结果：5.5消息面打败了27%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	重大事项	公司股东股份解押	2025-04-03
一般消息	募资投向	公司购买资产	2025-02-22
一般消息	重大事项	关联交易	2025-02-22
一般消息	股东大会	临时股东大会	2024-11-21
一般消息	重大事项	关联交易	2024-11-21
利好	分红转增	10派0.07元(含税)	2024-10-31
一般消息	分红转增	不分配不转增	2024-08-27
一般消息	资产重组	公司股权转让	2024-08-03
利好	分红转增	10派0.13元(含税)	2024-04-30

一年消息统计

	所有消息	重大消息	非重大消息
利好	2条	0条	2条
利空	0条	0条	0条

行业面诊股

诊断结果：6.0行业面打败了81%的股票医药商业行业最新资金流向

近10日来该行业走势总体向下，接近大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

行业面得分最高的股票

行业走势

近10日来该行业走势总体向下，接近大盘。

[{"date":"2025.04.18","price":"0.23","value":"-0.37"},{"date":"2025.04.17","price":"-0.16","value":"0.74"},{"date":"2025.04.16","price":"-0.85","value":"-1.23"},{"date":"2025.04.15","price":"-0.27","value":"0.11"},{"date":"2025.04.14","price":"0.51","value":"1.30"},{"date":"2025.04.11","price":"0.82","value":"-0.33"},{"date":"2025.04.10","price":"2.25","value":"1.99"},{"date":"2025.04.09","price":"1.22","value":"1.27"},{"date":"2025.04.08","price":"0.64","value":"1.75"},{"date":"2025.04.07","price":"-9.66","value":"-10.73"},{"date":"2025.04.03","price":"-1.40","value":"0.20"},{"date":"2025.04.02","price":"0.09","value":"0.05"},{"date":"2025.04.01","price":"-0.01","value":"2.74"},{"date":"2025.03.31","price":"-0.97","value":"-1.80"},{"date":"2025.03.28","price":"-0.57","value":"-1.13"},{"date":"2025.03.27","price":"0.23","value":"0.27"},{"date":"2025.03.26","price":"-0.05","value":"0.06"},{"date":"2025.03.25","price":"-0.43","value":"1.13"},{"date":"2025.03.24","price":"0.07","value":"-1.69"},{"date":"2025.03.21","price":"-1.76","value":"-1.72"},{"date":"2025.03.20","price":"-0.91","value":"-0.71"}]

深证成指,医药商业行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	益丰药房	12.17%	0.18%	5.3分
2	大参林	10.92%	-0.35%	5.4分
3	南京医药	-1.19%	4.63%	5.2分
4	一心堂	-3.15%	1.81%	4.5分
5	上海医药	-3.54%	-0.48%	5.4分
6	国药股份	-4.44%	-0.65%	4.6分
7	老百姓	-5.17%	-0.48%	4.5分
8	英特集团	-5.22%	2.78%	5.6分
9	嘉事堂	-5.49%	0.83%	5.1分
10	重药控股	-5.83%	0.41%	5.0分
11	中国医药	-6.15%	0.10%	4.1分
12	国药一致	-6.59%	0.16%	5.1分
13	九州通	-6.65%	-1.04%	4.6分
14	浙江震元	-6.93%	1.32%	4.9分
15	海王生物	-6.97%	0.00%	5.0分
16	瑞康医药	-7.57%	0.72%	4.8分
17	鹭燕医药	-7.66%	1.95%	4.7分
18	柳药集团	-9.58%	0.66%	4.6分
19	第一医药	-9.60%	0.75%	4.7分
20	华人健康	-9.72%	0.91%	4.3分
21	开开实业	-9.78%	2.61%	4.6分
22	健之佳	-9.96%	0.40%	3.9分
23	人民同泰	-10.18%	1.67%	4.4分
24	达嘉维康	-11.68%	0.77%	4.6分
25	漱玉平民	-12.33%	1.04%	4.7分
26	药易购	-12.79%	1.20%	4.3分
27	国科恒泰	-13.01%	0.10%	4.6分
28	合富中国	-13.57%	1.43%	4.1分
29	百洋医药	-17.21%	-0.92%	5.2分
30	润达医疗	-20.89%	-3.85%	3.2分
31	塞力医疗	-23.85%	-2.33%	3.1分

<上一页 1 2 3 4 5 6 下一页>

行业评级

最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

综合评级

研究机构	评级日期	最新评级	上次评级
中信证券	2012-09-10	增持	增持
招商证券	2012-09-08	增持	增持
航天证券	2012-09-06	增持	-
中银国际	2012-09-05	增持	-
齐鲁证券	2012-09-05	增持	-

基本面诊股

诊断结果：4.9基本面打败了14%的股票连续3年业绩增长30%的公司

该公司运营状况尚可，暂时未获得多数机构的显著认同，后续可继续关注。

个股深一度

潜在高分红能力：弱（32.5分）

基本面得分最高的股票

[ 截止日期：2024-09-30 ]公司经营

盈利能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 29/72 ， 16/72。

[{"date":"2024-09-30","value":"0.71","vol":"5.85"},{"date":"2024-06-30","value":"0.57","vol":"4.44"},{"date":"2024-03-31","value":"0.28","vol":"2.30"},{"date":"2023-12-31","value":"0.37","vol":"7.23"},{"date":"2023-09-30","value":"0.35","vol":"7.28"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
净资产收益率(%)	0.71	0.57	0.28	0.37	0.35
行业(%)	5.85	4.44	2.30	7.23	7.28

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2024-09-30","value":"13.06","vol":"17.89"},{"date":"2024-06-30","value":"12.55","vol":"17.84"},{"date":"2024-03-31","value":"12.04","vol":"17.80"},{"date":"2023-12-31","value":"10.29","vol":"17.83"},{"date":"2023-09-30","value":"13.41","vol":"18.09"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
销售毛利率(%)	13.06	12.55	12.04	10.29	13.41
行业(%)	17.89	17.84	17.80	17.83	18.09

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 21/72 ， 2/72。

[{"date":"2024-09-30","value":"-0.80","vol":"2.06"},{"date":"2024-06-30","value":"-1.18","vol":"1.88"},{"date":"2024-03-31","value":"-2.62","vol":"4.80"},{"date":"2023-12-31","value":"-34.74","vol":"4.27"},{"date":"2023-09-30","value":"-43.97","vol":"6.21"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
营业收入同比增长率(%)	-0.80	-1.18	-2.62	-34.74	-43.97
行业(%)	2.06	1.88	4.80	4.27	6.21

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2024-09-30","value":"101.90","vol":"-50.40"},{"date":"2024-06-30","value":"1.17","vol":"-17.67"},{"date":"2024-03-31","value":"-28.31","vol":"3.54"},{"date":"2023-12-31","value":"101.11","vol":"2.19"},{"date":"2023-09-30","value":"-68.54","vol":"10.40"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
净利润同比增长率(%)	101.90	1.17	-28.31	101.11	-68.54
行业(%)	-50.40	-17.67	3.54	2.19	10.40

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 31/72 ， 14/72。

[{"date":"2024-09-30","value":"0.37","vol":"0.89"},{"date":"2024-06-30","value":"0.25","vol":"0.60"},{"date":"2024-03-31","value":"0.13","vol":"0.31"},{"date":"2023-12-31","value":"0.46","vol":"1.24"},{"date":"2023-09-30","value":"0.34","vol":"0.91"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
总资产周转率(次)	0.37	0.25	0.13	0.46	0.34
行业(次)	0.89	0.60	0.31	1.24	0.91

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2024-09-30","value":"5.24","vol":"4.52"},{"date":"2024-06-30","value":"3.45","vol":"3.08"},{"date":"2024-03-31","value":"1.69","vol":"1.58"},{"date":"2023-12-31","value":"6.95","vol":"6.32"},{"date":"2023-09-30","value":"6.07","vol":"4.72"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
存货增长率(次)	5.24	3.45	1.69	6.95	6.07
行业(次)	4.52	3.08	1.58	6.32	4.72

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2024-09-30","value":"0.10","vol":"4.01"},{"date":"2024-06-30","value":"3.15","vol":"6.46"},{"date":"2024-03-31","value":"-2.68","vol":"-3.83"},{"date":"2023-12-31","value":"-12.96","vol":"10.23"},{"date":"2023-09-30","value":"7.60","vol":"2.62"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
现金流量净额/营业收入	0.10	3.15	-2.68	-12.96	7.60
行业	4.01	6.46	-3.83	10.23	2.62

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"0.21","vol":"0.77"},{"date":"2024-03-31","value":"","vol":"0.00"},{"date":"2023-12-31","value":"1.22","vol":"1.02"},{"date":"2023-09-30","value":"","vol":"0.00"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
资本支出／折旧和摊销	-	0.21	-	1.22	-
行业	0.00	0.77	0.00	1.02	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 25/72 ， 2/72。

[{"date":"2024-09-30","value":"1.14","vol":"1.47"},{"date":"2024-06-30","value":"1.12","vol":"1.49"},{"date":"2024-03-31","value":"1.09","vol":"1.51"},{"date":"2023-12-31","value":"1.07","vol":"1.51"},{"date":"2023-09-30","value":"1.05","vol":"1.48"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
流动比率	1.14	1.12	1.09	1.07	1.05
行业	1.47	1.49	1.51	1.51	1.48

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2024-09-30","value":"1.02","vol":"1.04"},{"date":"2024-06-30","value":"1.00","vol":"1.06"},{"date":"2024-03-31","value":"0.97","vol":"1.09"},{"date":"2023-12-31","value":"0.95","vol":"1.07"},{"date":"2023-09-30","value":"0.97","vol":"1.06"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
速动比率	1.02	1.00	0.97	0.95	0.97
行业	1.04	1.06	1.09	1.07	1.06

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 20/72 ， 15/72。

[{"date":"2024-09-30","value":"65.25","vol":"61.64"},{"date":"2024-06-30","value":"63.79","vol":"61.18"},{"date":"2024-03-31","value":"63.65","vol":"61.00"},{"date":"2023-12-31","value":"66.26","vol":"60.66"},{"date":"2023-09-30","value":"67.32","vol":"61.05"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
资产负债率(%)	65.25	63.79	63.65	66.26	67.32
行业(%)	61.64	61.18	61.00	60.66	61.05

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2024-09-30","value":"1.95","vol":"2.19"},{"date":"2024-06-30","value":"1.82","vol":"2.15"},{"date":"2024-03-31","value":"1.81","vol":"2.15"},{"date":"2023-12-31","value":"2.03","vol":"2.12"},{"date":"2023-09-30","value":"2.14","vol":"2.07"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
产权比率 (%)	1.95	1.82	1.81	2.03	2.14
行业(%)	2.19	2.15	2.15	2.12	2.07

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构对该股票关注较少，无任何评级。

研究机构	评级日期	最新评级	上次评级
暂无数据

机构预测

暂时还没有机构预测该股2024年的收益，请投资者后续关注。

[{"date":"2020","yellowRectValue":"2.61","blueLineValue":"","type":""},{"date":"2021","yellowRectValue":"1.31","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"-18.31","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.20","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]

[瑞康医药]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]